EcoDrugPlus

Ensembl ID : ENSVPAG00000002035
Gene Symbol: -
Cross references: -
209 Possible Orthologues:

Ensembl ID : ENSVPAG00000001866
Gene Symbol: -
Cross references: -
199 Possible Orthologues:

Ensembl ID : ENSVPAG00000001109
Gene Symbol: -
Cross references: -
206 Possible Orthologues:

Ensembl ID : ENSVPAG00000000711
Gene Symbol: -
Cross references: -
259 Possible Orthologues:

Ensembl ID : ENSVPAG00000000574
Gene Symbol: -
Cross references: -
277 Possible Orthologues:

Ensembl ID : ENSVPAG00000000569
Gene Symbol: -
Cross references: -
267 Possible Orthologues:

Ensembl ID : ENSVPAG00000000455
Gene Symbol: -
Cross references: -
208 Possible Orthologues:

Ensembl ID : ENSVPAG00000000396
Gene Symbol: -
Cross references: -
116 Possible Orthologues:

Ensembl ID : ENSVPAG00000000253
Gene Symbol: -
Cross references: -
283 Possible Orthologues:

Ensembl ID : ENSVPAG00000000127
Gene Symbol: -
Cross references: -
453 Possible Orthologues:

Ensembl ID : ENSVPAG00000012591
Gene Symbol: -
Cross references: -
234 Possible Orthologues:

Ensembl ID : ENSVPAG00000012532
Gene Symbol: -
Cross references: -
297 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).